ThinkSabio

$OCS

$7.46▲ +2.8% YTD

4 SEC 13D/G filings tracked · Last updated Oct 20, 2026

Filing History
News
OCS ▲ +2.8% - Oculis Holding AG
CP $7.46▲ +2.8%Oct 20, 2026 · ThinkSabio Blog

$OCS - Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting…

News
OCS ▼ -1.4% - Oculis Holding AG
CP $7.29▲ -1.4%Oct 19, 2026 · ThinkSabio Blog

$OCS - Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease…

News
OCS ▲ +1.6% - Oculis Holding AG
CP $8.72▲ +1.6%Oct 7, 2026 · ThinkSabio Blog

$OCS - Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day…

News
OCS ▲ +2.1% - Oculis Holding AG
CP $9.34▲ +2.1%Oct 1, 2026 · ThinkSabio Blog

$OCS - Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS…